Everything tagged "backlog" across research, earnings, and macro.
7 articles
Rocket Lab’s drop looks more like a reset in sentiment than a break in the business story. The market is still treating RKLB like a speculative launch name even as defense contracts, backlog, and real-world execution say it is becoming something more durable.
Graham has moved into a more durable growth phase, powered by record backlog, defense-heavy demand, and improving margins. But the stock already prices in much of that progress, leaving a Hold case despite strong operating momentum.
Elbit Systems is evolving from a wartime demand spike into a backlog-driven growth story, with 2025 revenue up 16% and backlog reaching $28.1B. Strong cash generation, expanding capacity, and improving margins support a constructive view despite rich trailing valuation optics.
Babcock & Wilcox is showing a real operating recovery, with Q1 2026 revenue up 44% and backlog at $2.7B, but the stock still carries turnaround risk and accounting noise.
Sterling Infrastructure is evolving into a higher-margin specialty infrastructure operator with outsized exposure to data centers and mission-critical work. Strong backlog, rapid E-Infrastructure growth, and raised 2026 guidance support the Buy case, though valuation remains demanding.
EMCOR delivered record 2025 revenue, expanding margins, and a conservative balance sheet while demand in data centers and electrical construction accelerated. The stock looks expensive, but execution and backlog growth support a constructive Buy view.
Medpace is delivering fast revenue growth, strong backlog, and net cash, but the stock already prices in a lot of good news. The report leans constructive, with a selective Buy on pullbacks rather than an aggressive chase.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator